Search by Drug Name or NDC

    NDC 67618-0200-30 BETASEPT 0.04 mg/mL Details

    BETASEPT 0.04 mg/mL

    BETASEPT is a TOPICAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Atlantis Consumer Healthcare, Inc.. The primary component is CHLORHEXIDINE GLUCONATE.

    Product Information

    NDC 67618-0200
    Product ID 67618-200_38dcb5ed-dbcd-42dd-9851-23061fed37b1
    Associated GPIs 92100030100940
    GCN Sequence Number 007254
    GCN Sequence Number Description chlorhexidine gluconate LIQUID 4 % TOPICAL
    HIC3 Q5B
    HIC3 Description TOPICAL PREPARATIONS,ANTIBACTERIALS
    GCN 30011
    HICL Sequence Number 004297
    HICL Sequence Number Description CHLORHEXIDINE GLUCONATE
    Brand/Generic Generic
    Proprietary Name BETASEPT
    Proprietary Name Suffix n/a
    Non-Proprietary Name Antiseptic Surgical Scrub
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route TOPICAL
    Active Ingredient Strength 0.04
    Active Ingredient Units mg/mL
    Substance Name CHLORHEXIDINE GLUCONATE
    Labeler Name Atlantis Consumer Healthcare, Inc.
    Pharmaceutical Class Decreased Cell Wall Integrity [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019125
    Listing Certified Through 2024-12-31

    Package

    NDC 67618-0200-30 (67618020030)

    NDC Package Code 67618-200-30
    Billing NDC 67618020030
    Package 946 mL in 1 BOTTLE (67618-200-30)
    Marketing Start Date 1993-06-01
    NDC Exclude Flag N
    Pricing Information N/A